INCOME STATEMENT (Quarterly GAAP In millions $) |
(Sep 30 2023) III. Quarter |
(Jun 30 2023) II. Quarter |
(Mar 31 2023) I. Quarter |
(Dec 31 2022) IV. Quarter |
(Sep 30 2022) III. Quarter |
Proceeds From Sales Of I P |
- |
- |
- |
|
- |
Interests Expense |
- |
- |
- |
|
- |
Total Revenue |
0.00 |
0.00 |
0.00 |
-0.15 |
0.00 |
Financing Interest Expense |
- |
- |
0.01 |
- |
- |
Provision for Loan, Lease, and Other Losses |
- |
- |
- |
1.35 |
- |
Gross
Profit |
0.00 |
0.00 |
-0.01 |
-1.50 |
0.00 |
Selling, Administration, Marketing |
2.48 |
3.05 |
2.23 |
2.25 |
1.56 |
Depriciation & Amortization |
- |
- |
- |
- |
- |
Research and Development Expense |
1.95 |
1.11 |
1.43 |
0.94 |
3.00 |
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) |
- |
- |
- |
3.56 |
- |
Other operatinig exp. /-income |
- |
0.00 |
-0.01 |
-1.50 |
- |
Unusual Expense /-Income |
- |
- |
- |
- |
- |
Total operating costs including COS |
4.43 |
4.16 |
3.66 |
6.60 |
4.56 |
Operating income/-loss
|
-4.43 |
-4.16 |
-3.66 |
-6.75 |
-4.56 |
Other Deductions / - Income |
Interest expense |
0.03 |
0.14 |
0.09 |
0.04 |
0.04 |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
0.03 |
0.14 |
0.09 |
- |
0.04 |
Investment Income, Interest |
-0.01 |
0.00 |
0.00 |
- |
-0.01 |
Foreign Currency Transaction Gain (Loss), before Tax |
-0.16 |
-0.03 |
0.10 |
-0.51 |
-0.41 |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
Other loss/ -income |
-2.08 |
1.31 |
-3.83 |
0.73 |
-2.52 |
Liabilities Fair Value Adjustment |
- |
1.94 |
- |
3.68 |
- |
Total costs & expenses |
2.21 |
7.53 |
0.01 |
10.50 |
1.66 |
Income /-loss before income taxes |
-2.21 |
-7.53 |
-0.01 |
-10.65 |
-1.66 |
Income taxes expenses/-benefit |
- |
- |
- |
0.30 |
-0.01 |
Income after income taxes |
-2.21 |
-7.53 |
-0.01 |
-10.96 |
-1.65 |
Net income/-loss
of other equity |
- |
- |
- |
- |
- |
Income/-loss
from cont. Ops. |
-2.21 |
-7.53 |
-0.01 |
-10.96 |
-1.65 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
-2.21 |
-7.53 |
-0.01 |
-10.96 |
-1.65 |
Noncontrolling interests |
- |
- |
- |
- |
- |
Prefered dividends |
-1.11 |
-0.12 |
0.00 |
-1.57 |
-1.65 |
Other |
-4.45 |
-2.38 |
-3.35 |
-3.14 |
-5.03 |
Income/-loss to shareholder |
-5.55 |
-9.79 |
-3.36 |
-2.84 |
-5.04 |
EBIT |
-2.18 |
-7.38 |
0.08 |
-10.65 |
-1.62 |
EBITD |
-2.17 |
-7.37 |
0.09 |
-10.65 |
-1.61 |
EBITDA |
-2.17 |
-7.37 |
0.09 |
-10.65 |
-1.61 |